Literature DB >> 23995881

Increased signal intensity of prostate lesions on high b-value diffusion-weighted images as a predictive sign of malignancy.

Michael Quentin1, Lars Schimmöller, Christian Arsov, Robert Rabenalt, Gerald Antoch, Peter Albers, Dirk Blondin.   

Abstract

OBJECTIVES: The evaluation of lesions detected in prostate magnetic resonance imaging (MRI) with increased signal intensity (SI) on high b-value diffusion-weighted images as a sign of malignancy.
METHODS: One hundred and three consecutive patients with prostate MRI examination and MRI-guided in-bore biopsy were retrospectively included in the study. MRI-guided in-bore biopsy histologically confirmed prostate cancer in 50 patients (n = 92 lesions). The other 53 patients (n = 122 lesions) had negative bioptical results.
RESULTS: In patients with histologically confirmed prostate cancer, 46 of the 92 lesions had visually increased SI on the high b-value images compared with the peripheral zone (SI = +27 ± 16%) or the central gland (SI = +37 ± 19%, P < 0.001 respectively). In patients with a negative biopsy, ten of the 122 lesions had visually increased SI (compared with the peripheral zone, SI = +29 ± 18%, and with the central gland, SI = +41 ± 15%, P < 0.001 respectively). Neither the apparent diffusion coefficient (ADC) values nor the Gleason Score of lesions with increased SI were significantly different from lesions without increased SI.
CONCLUSIONS: Visually increased SI on the high b-value images of diffusion-weighted imaging using standard b-values is a sign of malignancy but can occasionally also be a feature of benign lesions. However, it does not indicate more aggressive tumours. KEY POINTS: • Diffusion weighted magnetic resonance imaging is increasingly used to diagnose prostatic cancer • Reduced signal intensity (SI) on apparent diffusion coefficient (ADC) mapping is characteristic • Prostatic tumours usually exhibit increased SI on high b-value images • But benign lesions can also yield increased SI on high b-value images.

Entities:  

Mesh:

Year:  2013        PMID: 23995881     DOI: 10.1007/s00330-013-2999-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  17 in total

1.  Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate.

Authors:  P Gibbs; D J Tozer; G P Liney; L W Turnbull
Journal:  Magn Reson Med       Date:  2001-12       Impact factor: 4.668

Review 2.  Prostate cancer: multiparametric MR imaging for detection, localization, and staging.

Authors:  Caroline M A Hoeks; Jelle O Barentsz; Thomas Hambrock; Derya Yakar; Diederik M Somford; Stijn W T P J Heijmink; Tom W J Scheenen; Pieter C Vos; Henkjan Huisman; Inge M van Oort; J Alfred Witjes; Arend Heerschap; Jurgen J Fütterer
Journal:  Radiology       Date:  2011-10       Impact factor: 11.105

3.  Statistical evaluation of diffusion-weighted imaging of the human kidney.

Authors:  Hans-Jörg Wittsack; Rotem S Lanzman; Christian Mathys; Hendrik Janssen; Ulrich Mödder; Dirk Blondin
Journal:  Magn Reson Med       Date:  2010-08       Impact factor: 4.668

4.  Comparison of biexponential and monoexponential model of diffusion weighted imaging in evaluation of renal lesions: preliminary experience.

Authors:  Hersh Chandarana; Vivian S Lee; Elizabeth Hecht; Bachir Taouli; Eric E Sigmund
Journal:  Invest Radiol       Date:  2011-05       Impact factor: 6.016

5.  Intravoxel incoherent motion perfusion MR imaging: a wake-up call.

Authors:  Denis Le Bihan
Journal:  Radiology       Date:  2008-12       Impact factor: 11.105

6.  Ultra-high b-value diffusion-weighted MRI for the detection of prostate cancer with 3-T MRI.

Authors:  Yoshiko Ueno; Kazuhiro Kitajima; Kazuro Sugimura; Fumi Kawakami; Hideaki Miyake; Makoto Obara; Satoru Takahashi
Journal:  J Magn Reson Imaging       Date:  2013-01-04       Impact factor: 4.813

7.  Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.

Authors:  Thomas Hambrock; Diederik M Somford; Henkjan J Huisman; Inge M van Oort; J Alfred Witjes; Christina A Hulsbergen-van de Kaa; Thomas Scheenen; Jelle O Barentsz
Journal:  Radiology       Date:  2011-05       Impact factor: 11.105

Review 8.  Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer.

Authors:  Michael A Jacobs; Ronald Ouwerkerk; Kyle Petrowski; Katarzyna J Macura
Journal:  Top Magn Reson Imaging       Date:  2008-12

9.  High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio.

Authors:  Kazuhiro Kitajima; Yasushi Kaji; Kagayaki Kuroda; Kazuro Sugimura
Journal:  Magn Reson Med Sci       Date:  2008       Impact factor: 2.471

10.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

View more
  6 in total

Review 1.  Clinical and research applications of simultaneous positron emission tomography and MRI.

Authors:  F Fraioli; S Punwani
Journal:  Br J Radiol       Date:  2013-11-14       Impact factor: 3.039

2.  Potential of diffusion-weighted imaging in magnetic resonance enterography to identify neoplasms in the ileocecal region: Use of ultra-high b-value diffusion-weighted imaging.

Authors:  Hao Yu; Cui Feng; Zi Wang; Jianjun Li; Yanchun Wang; Xuemei Hu; Zhen Li; Yaqi Shen; Daoyu Hu
Journal:  Oncol Lett       Date:  2019-06-05       Impact factor: 2.967

Review 3.  Multiparametric MRI in prostate cancer management.

Authors:  Linda M Johnson; Baris Turkbey; William D Figg; Peter L Choyke
Journal:  Nat Rev Clin Oncol       Date:  2014-05-20       Impact factor: 66.675

4.  Usefulness of diffusion-weighted MR imaging for differentiating between benign and malignant superficial soft tissue tumours and tumour-like lesions.

Authors:  Ji Young Jeon; Hye Won Chung; Min Hee Lee; Sang Hoon Lee; Myung Jin Shin
Journal:  Br J Radiol       Date:  2016-02-19       Impact factor: 3.039

5.  MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy.

Authors:  Lars Schimmöller; Michael Quentin; Christian Arsov; Andreas Hiester; Christian Buchbender; Robert Rabenalt; Peter Albers; Gerald Antoch; Dirk Blondin
Journal:  Eur Radiol       Date:  2014-06-28       Impact factor: 5.315

6.  Feasibility of multiparametric prostate magnetic resonance imaging in the detection of cancer distribution: histopathological correlation with prostatectomy specimens.

Authors:  Kosuke Kitamura; Satoru Muto; Isao Yokota; Kazutane Hoshimoto; Tatsuro Kaminaga; Takahiro Noguchi; Syou-Ichiro Sugiura; Hisamitsu Ide; Raizo Yamaguchi; Shigeru Furui; Shigeo Horie
Journal:  Prostate Int       Date:  2014-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.